Abstract
The recent emergence of multimodality imaging, particularly the combination of PET and MRI, has led to excitement over the prospect of improving detection of disease. Iron oxide nanoparticles have become a popular platform for the fabrication of PET/MRI probes owing to their advantages of high MRI detection sensitivity, biocompatibility, and biodegradability. In this article, we report the synthesis of dextran-coated iron oxide nanoparticles (DIO) labeled with the positron emitter 64Cu to generate a PET/MRI probe, and modified with maleic anhydride to increase the negative surface charge. The modified nanoparticulate PET/MRI probe (MDIO-64Cu-DOTA) bears repetitive anionic charges on the surface that facilitate recognition by scavenger receptor type A (SR-A), a ligand receptor found on activated macrophages but not on normal vessel walls. MDIO-64Cu-DOTA has an average iron oxide core size of 7–8 nm, an average hydrodynamic diameter of 62.7 nm, an r 1 relaxivity of 16.8 mM−1 s−1, and an r 2 relaxivity of 83.9 mM−1 s−1 (37 °C, 1.4 T). Cell studies confirmed that the probe was nontoxic and was specifically taken up by macrophages via SR-A. In comparison with the nonmodified analog, the accumulation of MDIO in macrophages was substantially improved. These characteristics demonstrate the promise of MDIO-64Cu-DOTA for identification of vulnerable atherosclerotic plaques via the targeting of macrophages.
Similar content being viewed by others
References
Fuster V, Lois F, Franco M (2010) Nat Rev Cardiol 7:327–333
Chen W, Cormode DP, Fayad ZA, Mulder WJM (2011) Wiley Interdiscip Rev Nanomed Nanobiotechnol 3:146–161
Beyer T, Pichler B (2009) Eur J Nucl Med Mol Imaging 36:1–2
Cherry SR, Louie AY, Jacobs RE (2008) Proc IEEE 96:416–438
Marti-Bonmati L, Sopena R, Bartumeus P, Sopena P (2010) Contrast Media Mol Imaging 5:180–189
Zaidi H, Del Guerra A (2011) Med Phys 38:5667–5689
Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ (2010) Trends Mol Med 16:508–515
Ng TSC, Procissi D, Wu Y, Jacobs RE (2010) Med Phys 37:1995–2003
Louie A (2010) Chem Rev 110:3146–3195
Tu CQ, Ma XC, House A, Kauzlarich SM, Louie AY (2011) ACS Med Chem Lett 2:285–288
Tassa C, Shaw SY, Weissleder R (2011) Acc Chem Res 44:842–852
Xie J, Chen K, Huang J, Lee S, Wang JH, Gao J, Li XG, Chen XY (2010) Biomaterials 31:3016–3022
de Rosales RTM, Tavare R, Glaria A, Varma G, Protti A, Blower PJ (2011) Bioconjug Chem 22:455–465
Yang XQ, Hong H, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Xiao YL, Yang YA, Zhang Y, Nickles R, Cai WB, Steeber DA, Gong SQ (2011) Biomaterials 32:4151–4160
Liu Y, Welch MJ (2012) Bioconjug Chem 23:671–682
Tang TY, Muller KH, Graves MJ, Li ZY, Walsh SR, Young V, Sadat U, Howarth SPS, Gillard JH (2009) Arterioscler Thromb Vasc Biol 29:1001–1008
Woollard KJ, Geissmann F (2010) Nat Rev Cardiol 7:77–86
Libby P, DiCarli M, Weissleder R (2010) J Nucl Med 51:33S–37S
Moore KJ, Tabas I (2011) Cell 145:341–355
Nahrendorf M, Zhang HW, Hembrador S, Panizzi P, Sosnovik DE, Aikawa E, Libby P, Swirski FK, Weissleder R (2008) Circulation 117:379–387
Sadat U, Li ZY, Graves MJ, Tang TY, Gillard JH (2009) Nat Clin Pract Cardiovasc Med 6:200–209
Goldstein JL, Ho YK, Basu SK, Brown MS (1979) Proc Natl Acad Sci USA 76:333–337
Brown MS, Goldstein JL, Krieger M, Ho YK, Anderson RGW (1979) J Cell Biol 82:597–613
Tu CQ, Ma XC, Pantazis P, Kauzlarich SM, Louie AY (2010) J Am Chem Soc 132:2016–2023
Neyen C, Pluddemann A, Roversi P, Thomas B, Cai L, van der Westhuyzen DR, Sim RB, Gordon S (2009) Biochemistry 48:11858–11871
Doi T, Higashino K, Kurihara Y, Wada Y, Miyazaki T, Nakamura H, Uesugi S, Imanishi T, Kawabe Y, Itakura H, Yazaki Y, Matsumoto A, Kodama T (1993) J Biol Chem 268:2126–2133
Greaves DR, Gordon S (2009) J Lipid Res 50:S282–S286
Liu Q, Hamblin MR (2005) Int J Immunopathol Pharmacol 18:391–402
Jarrett BR, Gustafsson B, Kukis DL, Louie AY (2008) Bioconjug Chem 19:1496–1504
Tu C, Ng TSC, Sohi HK, Palko HA, House A, Jacobs RE, Louie AY (2011) Biomaterials 32:7209–7216
Jarrett BR, Correa C, Ma KL, Louie AY (2010) PLoS One 5:e13254
Jarrett BR, Frendo M, Vogan J, Louie AY (2007) Nanotechnology 18:035603
Wunderbaldinger P, Josephson L, Weissleder R (2002) Acad Radiol 9:S304–S306
Gustafsson B, Youens S, Louie AY (2006) Bioconjug Chem 17:538–547
Feeney RE, Yamasaki RB, Geoghegan KF (1982) Adv Chem Ser 198:3–55
Anderegg G, Arnaud-Neu F, Delgado R, Felcman J, Popov K (2005) Pure Appl Chem 77:1445–1495
Jones-Wilson TM, Deal KA, Anderson CJ, McCarthy DW, Kovacs Z, Motekaitis RJ, Sherry AD, Martell AE, Welch MJ (1998) Nucl Med Biol 25:523–530
Hargreaves MK, Stevinson EA (1964) Spectrochim Acta 20:317–324
Predoi D (2007) Dig J Nanomater Biostruct 2:169–173
Tu CQ, Louie AY (2012) WIREs Nanomed Nanobiotechnol 4:448–457
Obeidat WM, Schwabe K, Muller RH, Keck CM (2010) Eur J Pharm Biopharm 76:56–67
Gossuin Y, Gillis P, Hocq A, Vuong QL, Roch A (2009) Wiley Interdiscip Rev Nanomed Nanobiotechnol 1:299–310
Alford R, Simpson HM, Duberman J, Hill GC, Ogawa M, Regino C, Kobayashi H, Choyke PL (2009) Mol Imaging 8:341–354
Longmire MR, Ogawa M, Hama Y, Kosaka N, Regino CAS, Choyke PL, Kobayashi H (2008) Bioconjug Chem 19:1735–1742
Christie RJ, Tadiello CJ, Chamberlain LM, Grainger DW (2009) Bioconjug Chem 20:476–480
O’Brien J, Wilson I, Orton T, Pognan F (2000) Eur J Biochem 267:5421–5426
de Rosales RTM, Tavare R, Paul RL, Jauregui-Osoro M, Protti A, Glaria A, Varma G, Szanda I, Blower PJ (2011) Angew Chem Int Ed 50:5509–5513
Barreto JA, Matterna M, Graham B, Stephan H, Spiccia L (2011) New J Chem 35:2705–2712
Glaus C, Rossin R, Welch MJ, Bao G (2010) Bioconjug Chem 21:715–722
Greaves DR, Gordon S (2005) J Lipid Res 46:11–20
Platt N, Gordon S (2001) J Clin Invest 108:649–654
Osborn EA, Jaffer FA (2008) Curr Opin Cardiol 23:620–628
Shaw SY (2009) Nat Rev Cardiol 6:569–579
Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JGS, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA (2007) Proc Natl Acad Sci USA 104:961–966
Hamzah J, Kotamraju VR, Seo JW, Agemy L, Fogal V, Mahakian LM, Peters D, Roth L, Gagnon MKJ, Ferrara KW, Ruoslahti E (2011) Proc Natl Acad Sci USA 108:7154–7159
Uchida M, Kosuge H, Terashima M, Willits DA, Liepold LO, Young MJ, McConnell MV, Douglas T (2011) ACS Nano 5:2493–2502
Choudhury RP, Fisher EA (2009) Arterioscler Thromb Vasc Biol 29:983–991
Wang AZ, Gu F, Zhang LF, Chan JM, Radovic-Moreno A, Shaikh MR, Farokhzad OC (2008) Expert Opin Biol Ther 8:1063–1070
Talekar M, Kendall J, Denny W, Garg S (2011) Anticancer Drugs 22:949–962
Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (2010) Arterioscler Thromb Vasc Biol 30:1282–1292
Acknowledgments
The authors wish to acknowledge the National Institutes of Health (EB008576-01 and EB000993), the Center for Molecular and Genomic Imaging at the University of California, Davis (U24 CA 110804), and the NMR award of the University of California, Davis for support of this work. We thank Jeongchan Park, Jai Woong Seo, and Ray Wong for help with TEM imaging, zeta potential measurements, and IR spectroscopy, respectively.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: Valerie C. Pierre.
Rights and permissions
About this article
Cite this article
Tu, C., Ng, T.S.C., Jacobs, R.E. et al. Multimodality PET/MRI agents targeted to activated macrophages. J Biol Inorg Chem 19, 247–258 (2014). https://doi.org/10.1007/s00775-013-1054-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-013-1054-9